The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). حسب Yunmeng Da (707943)

Significant variables in decreasing importance for varietal clustering based on Random forest method. حسب Wilfried Chevalier (10521466)

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

Trend of TI values with age: The TI values decreased significantly with the increase of age, * p<0.01 vs other groups. حسب Yunmeng Da (707943)

Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue. حسب Jian-Bin Yin (19556105)

Viloxazine Extended-Release: A Review of in Attention-Deficit/Hyperactivity Disorder in Adults حسب Yahiya Y. Syed (6594444)

"…</p><p><br></p><p dir="ltr"><b>Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability</b> not applicable</p><p><br></p><p dir="ltr">Additional information about this Adis Drug Review can be found <a href="https://www.springer.com/gp/adis/products-services/adis-journals-newsletters/adis-drug-reviews" target="_blank">here</a></p><p><br></p><p dir="ltr"><b>Abstract</b></p><p dir="ltr">An extended-release once-daily oral capsule formulation of viloxazine (viloxazine ER; Qelbree®), a norepinephrine reuptake inhibitor and serotonin receptor modulator, has been approved in the USA for the treatment of attention-deficit/hyperactivity disorder (ADHD) in paediatric patients and adults. …"

Significant decrease of the coiled-coil score in the double proline-substituted CAHS3 mutant. حسب Akihiro Tanaka (342394)

Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use حسب Hannah A. Blair (13864794)

"…</p> <p><br></p> <p>  </p> <p><strong>Abstract </strong>Sodium oxybate extended-release suspension (LUMRYZ™; hereafter referred to as sodium oxybate ER) represents a promising novel option for the treatment of narcolepsy. …"

Number of participants showing improved, decreased, or no change in task performance with and without PSAPs. حسب Maxime Perron (16618003)

Motivation for sustained–delivery implants for treatment of PDAC. حسب Adrianne L. Jenner (11133854)

الموضوعات:

Combined decitabine and Taxol decreases MCF-7/Taxol cells proliferation and can improve their chemosensitivity. حسب Weihua Gong (471435)

Geniposide(Gen) significantly decreased the levels of TNF-α and MIP-1α in BALF of bleomycin-induced PF mice. حسب Jian-Bin Yin (19556105)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. حسب Orna Mizrahi-Man (42539)

Comparison of different fibre release and placement options. حسب Adrianne L. Jenner (11133854)

الموضوعات:

Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review حسب Cayley Russell (8087372)

"…Among other barriers, daily dosing requirements hinder treatment continuity post-release. Extended-release buprenorphine (XR-BUP) may therefore be beneficial. …"

GTDE decreased the expression of the NLRP3 inflammasome and AGEs in the cerebral cortex. حسب Hui-Chuan Kuo (12368492)

الموضوعات:

Phase 2 significant effects. حسب Wendy C. Crone (2262169)

Phase 1 significant effects. حسب Wendy C. Crone (2262169)

The expression of miR-122 is decreased as liver fibrosis progressed. حسب Young Chang (3666829)

الموضوعات:

Effect of extended-release buprenorphine (1 mg/kg SC) on tactile hypersensitivity in a rat model of inflammation. حسب Christina M. Larson (18196213)

"…<p>The mechanical nociceptive threshold is transiently changed by extended-release buprenorphine. Initial hypersensitivity tested at time point 0 was compared to time points following administration of extended-release buprenorphine (Bupe ER). …"